Serum fibroblast growth factor-23 concentration in dogs with myxomatous mitral valve disease
Journal of Veterinary Internal Medicine · 01.09.2026 · 40 (5)
DOI: 10.1093/jvimsj/aalag265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 29.10.2026. Verfasst von Naoki Iwasa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hashima Animal Hospital, Gifu 501-6625, Japan. Hauptthemen laut MEDLINE: Dog Diseases, Fibroblast Growth Factors, Heart Valve Diseases, Mitral Valve Insufficiency. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Circulating fibroblast growth factor-23 (FGF-23) is primarily a kidney-related biomarker, but also may be influenced by cardiovascular remodeling and hemodynamic load. Hypothesis/Objectives Verify whether serum FGF-23 concentration increases with myxomatous mitral valve disease (MMVD) severity. Animals Forty-two client-owned dogs with MMVD without overt kidney disease.
Methods
Retrospective cross-sectional study to evaluate serum FGF-23, N-terminal pro-B-type natriuretic peptide (NT-proBNP), atrial natriuretic peptide (ANP), blood urea nitrogen (BUN), creatinine (Cr), and symmetric dimethylarginine (SDMA) concentrations. Imaging variables included vertebral heart score (VHS), vertebral left atrial size (VLAS), left atrial-to-aortic root ratio (LA/Ao), normalized left-ventricular internal diameter in diastole (LVIDDN), and diastolic transmitral E-wave velocity (E-vel). Differences among American College of Veterinary Internal Medicine stages were analyzed using the Kruskal–Wallis test with Bonferroni-adjusted pairwise comparisons. Correlations were analyzed using Spearman’s correlation. Multivariable linear regression analysis was performed to identify factors associated with serum FGF-23 concentration.
Results
Dogs with ACVIM stages C and D had higher serum FGF-23 concentrations than those with stages B1 and B2 (P < .05). Serum FGF-23 concentrations were positively correlated with VLAS (rs = 0.500, P < .01), ANP (rs = 0.455, P < .01), LA/Ao (rs = 0.384, P < .05), E-vel (rs = 0.372, P < .05), and NT-proBNP (rs = 0.366, P < .05). ACVIM stage was significantly associated with serum FGF-23 concentration after adjustment for serum Cr concentration and loop diuretic use. Conclusions and clinical importance The potential influence of MMVD should be considered when interpreting increased circulating FGF-23 concentrations in dogs with MMVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hashima Animal Hospital, Gifu 501-6625, Japan.
- Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193, Japan.
- Gifu University Animal Medical Center, Gifu 501-1193, Japan.
- Orchid Animal Oncology and Orthopedic Center, Tokyo 120-0035, Japan.
ORCID-Profile: Naoki Iwasa, Mamu Shimizu, Tomoko Okamoto, Hiroto Kosuga, Nayu Morikita, Mifumi Kawabe, Munetaka Iwata, Kazuhiro Watanabe, Yui Kobatake, Satoshi Takashima, Naohito Nishii
Zitieren
APA
Iwasa, N., Shimizu, M., Okamoto, T., Kosuga, H., Morikita, N., Kawabe, M., Iwata, M., Watanabe, K., Kobatake, Y., Takashima, S., & Nishii, N. (2026). Serum fibroblast growth factor-23 concentration in dogs with myxomatous mitral valve disease. Journal of Veterinary Internal Medicine, 40(5). https://doi.org/10.1093/jvimsj/aalag265
Vancouver
Iwasa N, Shimizu M, Okamoto T, Kosuga H, Morikita N, Kawabe M, et al. Serum fibroblast growth factor-23 concentration in dogs with myxomatous mitral valve disease. Journal of Veterinary Internal Medicine. 2026;40(5). doi:10.1093/jvimsj/aalag265
BibTeX
@article{Iwasa2026,
author = {Iwasa, Naoki and Shimizu, Mamu and Okamoto, Tomoko and Kosuga, Hiroto and Morikita, Nayu and Kawabe, Mifumi and Iwata, Munetaka and Watanabe, Kazuhiro and Kobatake, Yui and Takashima, Satoshi and Nishii, Naohito},
title = {Serum fibroblast growth factor-23 concentration in dogs with myxomatous mitral valve disease},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
volume = {40},
number = {5},
doi = {10.1093/jvimsj/aalag265}
}
EUVIMED